抗高血压治疗与2型糖尿病风险 - Suppr

Suppr

超能文献

Antihypertensive therapy and the risk of type 2 diabetes mellitus.

作者信息

Sowers J R, Bakris G L

出版信息

N Engl J Med. 2000 Mar 30;342(13):969-70. doi: 10.1056/NEJM200003303421310.

DOI:10.1056/NEJM200003303421310

PMID:10738057

Abstract

摘要

相似文献

Antihypertensive therapy and the risk of type 2 diabetes mellitus.

N Engl J Med. 2000 Mar 30;342(13):969-70. doi: 10.1056/NEJM200003303421310.

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

N Engl J Med. 2000 Mar 30;342(13):905-12. doi: 10.1056/NEJM200003303421301.

The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?

Nephrol Dial Transplant. 2008 Nov;23(11):3389-91. doi: 10.1093/ndt/gfn455. Epub 2008 Aug 7.

[Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].

MMW Fortschr Med. 2004 Dec 16;146(51-52):51.

Impact of ASCOT on hypertension treatment and guidelines in older adults.

Age Ageing. 2006 May;35(3):214-7. doi: 10.1093/ageing/afj085.

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

Curr Med Res Opin. 2007 Jun;23(6):1239-44. doi: 10.1185/030079907X188044. Epub 2007 Apr 23.

[Antihypertensive medication and sleep].

Dtsch Med Wochenschr. 1998 Nov 13;123(46):1389-94. doi: 10.1055/s-2007-1024193.

[Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].

Wien Klin Wochenschr. 1995;107(21):629-39.

Blood pressure reduction is not the only determinant of outcome.

Circulation. 2006 Jun 13;113(23):2754-72; discussion 2773-4. doi: 10.1161/CIRCULATIONAHA.105.588020.

The importance of blood pressure control.

Prof Nurse. 2004 Nov;20(3):48.

引用本文的文献

MiR-150 blunts cardiac dysfunction in mice with cardiomyocyte loss of β-adrenergic receptor/β-arrestin signaling and controls a unique transcriptome.

Cell Death Discov. 2022 Dec 30;8(1):504. doi: 10.1038/s41420-022-01295-9.

Assessment of Association between Antihypertensive Drug Use and Occurrence of New-onset Diabetes in South Indian Patients.

J Pharm Bioallied Sci. 2020 Jan-Mar;12(1):48-56. doi: 10.4103/jpbs.JPBS_168_19. Epub 2020 Jan 29.

Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.

Cardiovasc Diabetol. 2020 May 16;19(1):67. doi: 10.1186/s12933-020-01037-0.

Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort.

PLoS One. 2018 Apr 9;13(4):e0195459. doi: 10.1371/journal.pone.0195459. eCollection 2018.

Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension.

Mol Cell Biochem. 2017 Jun;430(1-2):91-98. doi: 10.1007/s11010-017-2957-5. Epub 2017 Feb 11.

Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes.

Eur Heart J. 2016 Mar 21;37(12):968-74. doi: 10.1093/eurheartj/ehv557. Epub 2015 Oct 27.

Reduced total and cause-specific mortality from walking and running in diabetes.

Med Sci Sports Exerc. 2014;46(5):933-9. doi: 10.1249/MSS.0000000000000197.

Walking and running produce similar reductions in cause-specific disease mortality in hypertensives.

Hypertension. 2013 Sep;62(3):485-91. doi: 10.1161/HYPERTENSIONAHA.113.01608. Epub 2013 Aug 12.

Targeting hypertension in patients with cardiorenal metabolic syndrome.

Curr Hypertens Rep. 2012 Oct;14(5):397-402. doi: 10.1007/s11906-012-0292-5.

Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.

J Zhejiang Univ Sci B. 2012 May;13(5):378-85. doi: 10.1631/jzus.B1100302.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验